I
Immunome, Inc. (IMNM)
NCM – Real Time Price. Currency in USD
19.96
+0.56 (2.89%)
At close: Jun 26, 2026, 4:00 PM EDT
19.96
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:19 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
19.96
+0.56 (2.89%)
At close: Jun 26, 2026, 4:00 PM EDT
19.96
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:19 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $582.7M significantly exceed its total debt $3.7M, ensuring strong financial flexibility
Total current assets $594.3M exceed Total current liabilities $27.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$61.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 21.68 | 6.05 | 10 | |
| Quick ratio | 21.68 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 14M | 9M | 7M | 4M |
| Gross Profit | -631K | 13M | 7M | 4M | 1M |
| Operating Income | -37M | -110M | -153M | -214M | -229M |
| Net Income | -37M | -107M | -293M | -212M | -225M |
| EBITDA | -36M | -109M | -151M | -211M | -226M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -95.85 | -2.76 | 1.0 |
| Next quarter | N/A | 13.79 | 4.5 |
| Current year | -60.86 | 11.83 | 4.0 |
| Next year | 2073.16 | -0.86 | 5.5 |
| Weighted average score | 3.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 22.98 | 36.84 | -18.64 | 7.8 |
| Y/Y | -99.99 | -29.29 | 7.69 | -8.66 | 2.3 |
| 3y average | 313.43 | -112.07 | -5.2 | -434.52 | 3.3 |
| 5y average | 587.66 | -84.81 | -0.13 | -281.1 | 3.3 |
| Weighted average score | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |